dMed Global, a full-service Clinical Contract Research Organization (CRO) based in Shanghai, China, and Clinipace Incorporated, a full-service Clinical CRO with headquarters in North Carolina, USA, announced that the two companies will merge.
Innoforce and dMed have signed an agreement under which the two parties agreed to establish a partnership to identify, assess, and collaborate on the development of clinical-stage therapeutics.